RazinQ
ProductHeard on podcasts recently
RazinQ is identified as a cancer medicine approved for patients with metastatic pancreatic adenocarcinoma.
Discussed inMarkets100%
Rank this week
—
Not in this week’s list
Share of the conversation
—
Reach this week
—
Tone this week
—
Not enough signal yet (fewer than 3 episodes scored).
Share of the conversation
Mentions of RazinQ per 1,000 mentions of anything, 7-day rolling, all podcasts.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 26 | 0.01‰ | 1 |
| Aug 27 | 0.02‰ | 1 |
| Aug 28 | 0.03‰ | 1 |
| Sep 1 | 0.05‰ | 2 |
| Oct 30 | 0.02‰ | 2 |
| Nov 9 | 0.02‰ | 3 |
Discussed alongside
Names that come up in the same conversations as RazinQ.
Embed this
Paste this on your site to show RazinQ's current trend:
<iframe src="https://podlume.ai/embed/e/razinq" width="360" height="220" style="border:0" loading="lazy" title="RazinQ on PodLume Trends"></iframe>